Temporal lobe epilepsy (TLE) is a common and often devastating form of human epilepsy that lacks preventive therapy. Evidence from clinical and preclinical studies supports the idea that an episode of prolonged seizures (status epilepticus or SE) contributes to development of TLE. Defining the molecular mechanisms by which SE transforms a normal brain into an epileptic brain is essential for identifying molecular targets fo preventive therapies. Work accomplished during the current funding period revealed that transiently inhibiting the brain-derived neurotrophic factor (BDNF) receptor tyrosine kinase, TrkB, commencing following SE prevented SE-induced TLE. In preliminary studies we have discovered that global inhibition of TrkB signaling exacerbates SE-induced death of neurons, a detrimental outcome that must be mitigated. This led us to seek the downstream signaling pathway by which TrkB promotes epileptogenesis, our preliminary evidence implicating phospholipase Cy1 (PLCy1) as the dominant pathway. Our objective is to define the molecular mechanism by which SE induces TLE. To accomplish this objective, we propose to examine the effect of pharmacological uncoupling of TrkB from PLCy1 on cell death induced by SE in an adult mouse and on TLE induced by SE in a neonatal animal. We also propose to determine precisely when following SE that TrkB must be uncoupled from PLCy1 in order to prevent TLE in adults. Successful completion of the work proposed may pave the way to prevention of a subset of TLE, a common disorder of the human nervous system.

Public Health Relevance

Lack of effective prevention for common disorders of the human nervous system is a glaring unmet medical need critical to the mission of NINDS. The work proposed here represents a novel and innovative approach to uncover molecular signaling mechanisms underlying temporal lobe epilepsy. Such insights may pave the way to prevention of a subset of temporal lobe epilepsy, a common disorder of the human nervous system.

National Institute of Health (NIH)
Research Project (R01)
Project #
Application #
Study Section
Clinical Neuroplasticity and Neurotransmitters Study Section (CNNT)
Program Officer
Whittemore, Vicky R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
Schools of Medicine
United States
Zip Code
Liu, Gumei; Kotloski, Robert J; McNamara, James O (2014) Antiseizure effects of TrkB kinase inhibition. Epilepsia 55:1264-73
He, Xiao Ping; Wen, Renren; McNamara, James O (2014) Impairment of kindling development in phospholipase C?1 heterozygous mice. Epilepsia 55:456-63
Harward, Stephen C; McNamara, James O (2014) Aligning animal models with clinical epilepsy: where to begin? Adv Exp Med Biol 813:243-51
Liu, Gumei; Gu, Bin; He, Xiao-Ping et al. (2013) Transient inhibition of TrkB kinase after status epilepticus prevents development of temporal lobe epilepsy. Neuron 79:31-8
Harward, Stephen C; McNamara, James O (2013) In search of the ever-elusive positive endozepine. Neuron 78:951-2
Helgager, Jeffrey; Liu, Gumei; McNamara, James O (2013) The cellular and synaptic location of activated TrkB in mouse hippocampus during limbic epileptogenesis. J Comp Neurol 521:499-521, Spc1
Wang, Hong-Gang; He, Xiao Ping; Li, Qiang et al. (2013) The auxiliary subunit KChIP2 is an essential regulator of homeostatic excitability. J Biol Chem 288:13258-68
Pan, Enhui; Zhang, Xiao-an; Huang, Zhen et al. (2011) Vesicular zinc promotes presynaptic and inhibits postsynaptic long-term potentiation of mossy fiber-CA3 synapse. Neuron 71:1116-26
Danzer, Steve C; He, Xiaoping; Loepke, Andreas W et al. (2010) Structural plasticity of dentate granule cell mossy fibers during the development of limbic epilepsy. Hippocampus 20:113-24
Huang, Yang Z; McNamara, James O (2010) Mutual regulation of Src family kinases and the neurotrophin receptor TrkB. J Biol Chem 285:8207-17

Showing the most recent 10 out of 17 publications